Anuja Java
LightNews LightNews
banner
anujajava.bsky.social
Anuja Java
@anujajava.bsky.social
660 followers 210 following 75 posts
Txp Neph @WUNephrology
Director Kidney Txp @stlouisva;
Co-chair Complement Diseases KDWG @clingenresource; Research Interests: complement, glomerular diseases & genetics
Posts Replies Media Videos
anujajava.bsky.social
We're proudly supporting BrainShield, a student-led initiative making a real impact in our community by providing high-quality helmets to underfunded schools!!

💥 So far:
$3,870 raised; 30 helmets donated; 65 amazing donors
🙏🙏 to everyone who’s supported! 💛

Join us: www.gofundme.com/f/helmets-fo...
Protect Young Athletes: Helmet Donations to Schools, organized by BrainShield
Every child deserves to play the sport they love—safely. But currently… BrainShield needs your support for Protect Young Athletes: Helmet Donations to Schools
www.gofundme.com
September 21, 2025 at 9:10 PM
anujajava.bsky.social
Faculty dinner @kidneycon.bsky.social! For those who missed:

Topics covered 😉
Metabolic changes when Emperor Penguins molt
How a lion’s kidney handles protein load after it eats a kudu
Best baseball movies
Kidney disease in athletes
Genetically engineered crops
Politics & Academia
May 2, 2025 at 6:45 PM
Reposted by Anuja Java
hswapnil.medsky.social
Congrats to @danieljdrucker.bsky.social for the. Breakthrough prize of 2025!

www.prnewswire.com/news-release...

(With Joel Habener, Jens Juul Holst, Lotte Bjerre Knudsen and Svetlana Mojsov for GLP1RAs)

#MedSky
BREAKTHROUGH PRIZE ANNOUNCES 2025 LAUREATES IN LIFE SCIENCES, FUNDAMENTAL PHYSICS, AND MATHEMATICS
"Oscars® of Science" Awards Six $3 Million Prizes GLP-1 Diabetes and Obesity Discovery | Multiple Sclerosis Causes and Treatments | DNA Editing Exploration of...
www.prnewswire.com
April 5, 2025 at 11:44 PM
Reposted by Anuja Java
kidneymed.bsky.social
Resistance-Based Muscle Therapy, Frailty, and Muscle Biopsy Findings in Kidney Transplant Candidates: A Clinical Trial
www.kidneymedicinejournal.org
March 22, 2025 at 3:59 PM
Reposted by Anuja Java
hswapnil.medsky.social
The @nytimes.com with @danagoldstein.bsky.social cover the story of Dr Rasha Alawieh being deported despite the Judge’s order (gift link)

(She’s a nephrologist, not a surgeon, but that doesn’t matter here)

www.nytimes.com/2025/03/16/u...
Brown University Surgeon and Professor Are Deported to Lebanon Despite a Judge’s Order (Gift Article)
Dr. Rasha Alawieh, a kidney transplant specialist and Brown University professor who had a valid visa, was expelled in apparent defiance of a court order.
www.nytimes.com
March 16, 2025 at 7:54 PM
Reposted by Anuja Java
nkf-professionals.bsky.social
📢 SCM25 speakers! Let your network know you're presenting at SCM25 by sharing this graphic!

Reshare with your session details and help spread the word. Tag @NKF_NephPros and use #NKFClinicals!

🔗 Learn more about SCM25: bit.ly/4hdIliU

#Nephrology #MedEd
March 11, 2025 at 1:03 PM
anujajava.bsky.social
For all coffee lovers and for those who (like me) wonder why we still have daylight savings time 😊🤷‍♀️
March 11, 2025 at 4:44 PM
Reposted by Anuja Java
hswapnil.medsky.social
This week (and tonight on #NephJC) we are discussing the REGENCY trial on #obinutuzumab in SLE specifically #lupus nephritis

summary from
@sayalibthakare.bsky.social
@dramiliflores.bsky.social & @nephroseeker.medsky.social

www.nephjc.com/news/regency...

#lupuschat #NephSky #RheumSky
Obinutuzumab in Lupus Nephritis — NephJC
This week, we will celebrate in advance World Kidney Day by discussing the results of OBInutuzumab in active lupus nephritis. The LUNAR trial (rituximab versus placebo) was “almost” positive, but not ...
www.nephjc.com
March 11, 2025 at 12:56 PM
Reposted by Anuja Java
ajkd.bsky.social
On the #AJKDBlog, revisit these interviews with:
- Drs. Gaddy, Murugapandian, @amyaimei.bsky.social on viral nephropathy
-Dr. Anuja Java discusses benefits of clinical genetic testing
-Drs. Nair, Liu, @rasheedahall.bsky.social on frailty measurements

bit.ly/3ztk4VV (FREE)
March 10, 2025 at 10:00 PM
anujajava.bsky.social
Fantastic overview of the latest in APOL-1 kidney disease by @genetickidneydoc.bsky.social @glomcon.org today!!

Highlighted work from various labs @gbadegesinlab.bsky.social.
March 9, 2025 at 4:04 PM
Reposted by Anuja Java
ajkd.bsky.social
Happy #NephMadness Day!

The 8 regions of #NephMadness 2025 have been revealed on the #AJKDBlog. If you're a #NephMadnessNewbie, we explain everything here: buff.ly/DCZDRfN

Looking forward to the fun and learning with all of you!
Welcome to #NephMadness 2025
Here it is, the 13th edition of NephMadness!  Whether you’re new to the competition or just want to relive past glories, we have all the info you need for NephMadness 2025: What is NephMadnes…
buff.ly
March 1, 2025 at 1:36 PM
Reposted by Anuja Java
ajkd.bsky.social
Counting down the Top Ten #NephMadness region posts from 2020-2024:

5️⃣ Thrombotic Microangiopathy Region (2023) https://bit.ly/3ERRvV2

Expert: @anuja_java
Writer: @viral_nephro @AkbarNouman
Exec: @KidneyWars @Maximal_Change

Teams: Primary TMA vs Secondary TMA
February 24, 2025 at 4:01 PM
anujajava.bsky.social
Our review on Post-Transplant TMA is out in JASN!

In this series, we outline pathophysiologic mechanisms of TMA & diagnostic workflow.

🙏 @rajmehrotra.bsky.social & #DavidEllison
for invitation & fabulous co-authors @nephrosparks.bsky.social & #DavidKavanagh

journals.lww.com/jasn/abstrac...
Post-transplant Thrombotic Microangiopathy : Journal of the American Society of Nephrology
due to endothelial damage and microthrombi formation in small vessels. However, clinical features can range from a renal-limited form, diagnosed only on a kidney biopsy, to full-blown systemic manifes...
journals.lww.com
February 24, 2025 at 11:17 PM
Reposted by Anuja Java
hswapnil.medsky.social
Interesting read

www.nytimes.com/2025/02/17/o... ( #GiftLink)

We should not minimize the pain experience

#Medsky
Opinion | There’s One Lie I Will Never Tell My Children (Gift Article)
It’s “This won’t hurt.”
www.nytimes.com
February 20, 2025 at 8:10 AM
Reposted by Anuja Java
hswapnil.medsky.social
And her conclusion

Excellent highly densely packed TMA info from @anujajava.bsky.social

#NephSky #Isnwcn
Concluding slide
February 8, 2025 at 5:19 AM
Reposted by Anuja Java
hswapnil.medsky.social
Very cool algorithms from @anujajava.bsky.social

#ISNWCN #NephSky
Evaluation of TMA Risk stratification of TMA
February 8, 2025 at 5:19 AM
Reposted by Anuja Java
hswapnil.medsky.social
For primary/complement mediated - genetic testing and complement investigations (later often still research tools)

@anujajava.bsky.social stresses *not* to ignore VUS

#ISNWCN #NephSky
Genetic testing in TMA Complement investigations in TMA
February 8, 2025 at 5:19 AM
Reposted by Anuja Java
hswapnil.medsky.social
Move from primary/secondary to etiology

Nice framework for work up, more here www.sciencedirect.com/science/arti...

#ISNWCN #NephSky
Roadmap to changing TMA nomenclature TMA work up
February 8, 2025 at 5:09 AM
Reposted by Anuja Java
hswapnil.medsky.social
Next up is @anujajava.bsky.social on all about TMAs in 15 minutes

#ISNWCN #NephSky

Look at the changing terminology
Link: www.sciencedirect.com/science/arti...
Title slide Causes of TMA
February 8, 2025 at 5:09 AM
Reposted by Anuja Java
hswapnil.medsky.social
Quite an eclectic mix of topics and excellent speaker lineup

@anujajava.bsky.social
@bhallaresearch.bsky.social
Brad Rovin
Sush Waikar
Kelsie Bogyo

#ISNWCN #NephSky
Speaker line up Topic line up
February 8, 2025 at 4:20 AM
anujajava.bsky.social
Thrilled to share our center’s >decade experience of post-txp TMA @kireports.bsky.social

Retrospective study of 68 cases & 3467 controls.

Details of each pt’s clinical course, genetic etiology & functional studies in supplement.

www.sciencedirect.com/science/article/pii/S2468024925000518
Thrombotic Microangiopathy after Kidney Transplantation: Insights into Genetic Etiology and Clinical Outcomes
Thrombotic microangiopathy (TMA), marked by small vessel thrombosis from endothelial injury, presents significant diagnostic and treatment challenges …
www.sciencedirect.com
February 1, 2025 at 7:37 PM
Reposted by Anuja Java
washunephrology.bsky.social
Please join us in welcoming Mahmoud M. Musa, MD, as
@washunephrology.bsky.social's 2025 renal #transplant fellow. "I am deeply committed to advancing this field and contributing to better care for ESKD patients," says Dr. Musa.
t.co/XlpjubQNhg
January 28, 2025 at 8:35 PM
Reposted by Anuja Java
hswapnil.medsky.social
Quite poignant - but fitting that the new 2025 @kdigo.org ADPKD guidelines begin with a dedication to the late Tess Harris

www.kidney-international.org/article/S008...

#NephSky #ADPKD #PROMs
Dedication: Tess (Teresa) Harris, MA, FCIM (1956–2024): dedicated patient advocate in the fight against polycystic kidney disease (PKD) - page 1 Dedication: Tess (Teresa) Harris, MA, FCIM (1956–2024): dedicated patient advocate in the fight against polycystic kidney disease (PKD) - page 2
January 21, 2025 at 2:21 PM
Reposted by Anuja Java
washunephrology.bsky.social
Congratulations, @anujajava.bsky.social and co-authors!
January 6, 2025 at 5:47 PM